{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:43:02Z","timestamp":1786653782734,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To assess the current trends in use of perioperative antibiotic prophylaxis, especially intracameral antibiotics (ICAB), for cataract surgery in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was an E-survey using a previously validated questionnaire carried out by the All India Ophthalmological Society (AIOS) in August 2022. An E-mail invitation to complete an online 40-point survey was sent to all members of the AIOS using a digital E-mail service (Survey Monkey) and social media platforms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of 1804 total respondents, 58% (n = 1022) reported using routine ICAB prophylaxis. Of those using ICAB, 89% (n = 909) reported using it for all cases, whereas the rest used it for specific indications such as post-PC rent (n = 43), one eyed patient (n = 19), and high-risk cases (n = 50). Commercially available moxifloxacin was by far the commonest agent used for ICAB (n = 686, 67%). Eighty respondents (8%) reported noticing occasional toxic reactions and nontoxic corneal edema (n = 64, 6%) with ICAB. Surgeons with &gt;10 years\u2019 experience especially practicing in medical colleges used fewer ICAB (OR = 0.52, 95%CI = 0.38 \u2013 0.72,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0,001) compared to younger surgeons (&lt;5-year experience) in solo clinics. The commonest reason for nonadoption of IC antibiotics was \u201cunconvinced of the need to use it in my setting\u201d (n = 296, 52% of those who answered this question).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>IC antibiotic prophylaxis for cataract surgery has significantly increased in India from 40% in 2017 to 58% in 2022. Commercially available moxifloxacin was preferred by the majority users. Intraocular inflammation may occur occasionally and needs safer formulations to avoid this.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_702_23","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T07:55:41Z","timestamp":1692604541000},"page":"3235-3241","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Antibiotic prophylaxis for cataract surgery - Practice patterns amongst Indian Ophthalmologists"],"prefix":"10.4103","volume":"71","author":[{"given":"Aditya S","family":"Kelkar","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, National Institute of Ophthalmology, (NIO) Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Sharma","sequence":"additional","affiliation":[{"name":"Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Verma","sequence":"additional","affiliation":[{"name":"R.P. Centre, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha A","family":"Chandorkar","sequence":"additional","affiliation":[{"name":"Vitreo-Retinal Services, National Institute of Ophthalmology, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Saxena","sequence":"additional","affiliation":[{"name":"Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Regional Institute of Ophthalmology, IMS, BHU, Varanasi, UP, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai A","family":"Kelkar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Institute of Ophthalmology, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabhyasachi","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Future Vision Eye Care and Research Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"R1-20251008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/ICU.0000000000000326","article-title":"Endophthalmitis after cataract surgery: Epidemiology, risk factors, and evidence on protection","volume":"28","author":"Garg","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-20251008","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ophtha.2016.03.024","article-title":"Intracameral antibiotics and cataract surgery: Endophthalmitis rates, costs, and stewardship","volume":"123","author":"Schwartz","year":"2016","journal-title":"Ophthalmology"},{"key":"R3-20251008","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.survophthal.2020.04.006","article-title":"Commonly used intracameral antibiotics for endophthalmitis prophylaxis: A literature review","volume":"66","author":"Grzybowski","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"R4-20251008","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors","volume":"33","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R5-20251008","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00417-015-3009-z","article-title":"Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: An Israeli experience","volume":"253","author":"Katz","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20251008","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ophtha.2015.09.037","article-title":"Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind eye hospital","volume":"123","author":"Haripriya","year":"2016","journal-title":"Ophthalmology"},{"key":"R7-20251008","doi-asserted-by":"crossref","first-page":"17416","DOI":"10.1038\/s41598-022-21423-w","article-title":"Prophylactic antibiotics for postcataract surgery endophthalmitis: A systematic review and network meta-analysis of 6.8 million eyes","volume":"12","author":"Kato","year":"2022","journal-title":"Sci Rep"},{"key":"R8-20251008","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jcrs.2013.05.036","article-title":"Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan","volume":"39","author":"Matsuura","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R9-20251008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/1381612822666161216122230","article-title":"Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns around the world","volume":"23","author":"Grzybowski","year":"2017","journal-title":"Curr Pharm Des"},{"key":"R10-20251008","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2017.01.026","article-title":"Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: Analysis of 600 000 surgeries","volume":"124","author":"Haripriya","year":"2017","journal-title":"Ophthalmology"},{"key":"R11-20251008","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4103\/ijo.IJO_365_21","article-title":"Incidence of postoperative endophthalmitis with and without use of intracameral moxifloxacin","volume":"69","author":"Porwal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R12-20251008","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/ijo.IJO_1405_21","article-title":"Clinical features and microbiology of post-cataract surgery endophthalmitis with and without intracameral moxifloxacin prophylaxis: Endophthalmitis prophylaxis study report 3","volume":"70","author":"Dave","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R13-20251008","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4103\/ijo.IJO_1400_19","article-title":"Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India","volume":"68","author":"Rathi","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R14-20251008","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s10792-021-01830-0","article-title":"Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: Data from a tertiary eye care facility in rural India","volume":"41","author":"Shenoy","year":"2021","journal-title":"Int Ophthalmol"},{"key":"R15-20251008","first-page":"70362","article-title":"All India Ophthalmological Society (AIOS) Task Force guidelines to prevent intraocular infections and cluster outbreaks after cataract surgery","author":"Verma","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R16-20251008","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4103\/ijo.IJO_842_17","article-title":"Antibiotic prophylaxis practice patterns for cataract surgery in India-Results from an online survey","volume":"65","author":"Kelkar","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R17-20251008","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4103\/ijo.IJO_1336_17","article-title":"All India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017","volume":"66","author":"Maharana","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R18-20251008","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jcrs.2019.04.018","article-title":"Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries","volume":"45","author":"Haripriya","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R19-20251008","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4103\/ijo.IJO_1058_17","article-title":"Prevention and management of postoperative endophthalmitis: A case-based approach","volume":"65","author":"Verma","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R20-20251008","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jcrs.2015.01.014","article-title":"Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2014 ASCRS member survey","volume":"41","author":"Chang","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R21-20251008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/j.jcrs.0000000000000757","article-title":"Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2021 ASCRS member survey","volume":"48","author":"Chang","year":"2022","journal-title":"J Cataract Refract Surg"},{"key":"R22-20251008","first-page":"72","article-title":"Contemporary practices in cataract surgery-Subjective preferences of czech cataract surgeons","volume":"78","author":"Studen\u00fd","year":"2022","journal-title":"Cesk Slov Oftalmol"},{"key":"R23-20251008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4274\/tjo.galenos.2020.46020","article-title":"Evaluation of the cataract surgery 2018 survey in terms of achieving refractive cataract surgery targets","volume":"51","author":"Can","year":"2021","journal-title":"Turk J Ophthalmol"},{"key":"R24-20251008","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5301\/ejo.5000738","article-title":"Adherence to European Society for Cataract and Refractive Surgery recommendations among Italian cataract surgeons: A survey","volume":"26","author":"Grosso","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"R25-20251008","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2147\/OPTH.S64756","article-title":"Survey of Japanese ophthalmic surgeons regarding perioperative disinfection and antibiotic prophylaxis in cataract surgery","volume":"8","author":"Matsuura","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R26-20251008","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s10792-020-01493-3","article-title":"An investigation on the current patterns of using consumables and sterilizing accessories in phacoemulsification in China","volume":"40","author":"Qin","year":"2020","journal-title":"Int Ophthalmol"},{"key":"R27-20251008","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1442-9071.2010.02279.x","article-title":"Perioperative antibiotic prophylaxis during phaco-emulsification and intraocular lens implantation: National survey of smaller eye units in England","volume":"38","author":"Nanavaty","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R28-20251008","doi-asserted-by":"crossref","first-page":"257","DOI":"10.18502\/jovr.v14i3.4781","article-title":"Outbreak of multidrug-resistant pseudomonas aeruginosa endophthalmitis due to contaminated trypan blue solution","volume":"14","author":"Bawankar","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"key":"R29-20251008","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/09273948.2013.830752","article-title":"Outbreak of multidrug-resistant acute postoperative endophthalmitis due to Enterobacter aerogenes","volume":"22","author":"Bhat","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"R30-20251008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4103\/ijo.IJO_2537_21","article-title":"Emerging antimicrobial resistance and need for antimicrobial stewardship for ocular infections in India: A narrative review","volume":"70","author":"Biswas","year":"2022","journal-title":"Indian J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_702_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:42:20Z","timestamp":1786650140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_702_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_702_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"2023-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}